No data to show
XNAS
SOPH
Market cap202mUSD
May 02, Last price
3.03USD
1D
0.33%
1Q
-13.43%
IPO
-82.18%
Name
Sophia Genetics SA
Chart & Performance
P/E
—
P/S
3.11
EPS
—
Div Yield, %
—
Shrs. gr., 5y
0.68%
Rev. gr., 5y
20.77%
Revenues
65m
+4.49%
Net income
-62m
L-20.88%
CFO
-43m
L-11.84%
Earnings
May 05, 2025
Profile
SOPHiA GENETICS SA operates as a healthcare technology company. The company offers SOPHiA DDM platform, a cloud-based software-as-a-service platform for analyzing data and generating insights from multimodal data sets and diagnostic modalities. Its SOPHiA DDM platform and related solutions, products, and services are used by hospital, laboratory, and biopharma worldwide. SOPHiA GENETICS SA was incorporated in 2011 and is headquartered in Saint-Sulpice, Switzerland.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | |||||||
Revenues | 65,173 4.49% | 62,371 31.14% | 47,560 17.58% | ||||
Cost of revenue | 131,924 | 138,151 | 135,760 | ||||
Unusual Expense (Income) | |||||||
NOPBT | (66,751) | (75,780) | (88,200) | ||||
NOPBT Margin | |||||||
Operating Taxes | 1,223 | 486 | (136) | ||||
Tax Rate | |||||||
NOPAT | (67,974) | (76,266) | (88,064) | ||||
Net income | (62,493) -20.88% | (78,981) -9.68% | (87,449) 18.70% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 226 | 748 | |||||
BB yield | -0.07% | -0.57% | |||||
| Debt | |||||||
Debt current | 2,190 | 2,928 | 2,690 | ||||
Long-term debt | 44,633 | 34,274 | 30,796 | ||||
Deferred revenue | |||||||
Other long-term liabilities | 4,176 | 3,420 | 2,845 | ||||
Net debt | (33,403) | (86,049) | (145,126) | ||||
| Cash flow | |||||||
Cash from operating activities | (42,822) | (48,575) | (70,093) | ||||
CAPEX | (244) | (1,494) | (10,381) | ||||
Cash from investing activities | (8,176) | 8,320 | 41,973 | ||||
Cash from financing activities | 11,585 | (2,817) | (1,568) | ||||
FCF | (64,247) | (77,973) | (93,506) | ||||
| Balance | |||||||
Cash | 80,226 | 123,251 | 178,612 | ||||
Long term investments | |||||||
Excess cash | 76,967 | 120,132 | 176,234 | ||||
Stockholders' equity | (375,052) | (319,758) | (271,376) | ||||
Invested Capital | 505,748 | 493,221 | 490,738 | ||||
ROIC | |||||||
ROCE | |||||||
| EV | |||||||
Common stock shares outstanding | 66,062 | 64,751 | 64,099 | ||||
Price | 3.07 -34.82% | 4.71 128.64% | 2.06 -85.39% | ||||
Market cap | 202,811 -33.50% | 304,977 130.97% | 132,044 -85.33% | ||||
EV | 169,408 | 218,928 | (13,082) | ||||
EBITDA | (58,155) | (67,444) | (82,629) | ||||
EV/EBITDA | 0.16 | ||||||
Interest | 1,913 | 588 | 639 | ||||
Interest/NOPBT | |||||||